{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:10:15Z","timestamp":1794010215984,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bimodal neuromodulation combining sound therapy with electrical tongue stimulation using the Lenire\u00ae device is emerging as an effective treatment for tinnitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single-arm retrospective chart review of 220 patients with tinnitus from the Alaska Hearing &amp; Tinnitus Center examines the real-world outcomes of the recently FDA-approved Lenire treatment. To the best of our knowledge, this is the first assessment of Lenire from a real-world clinic in the United States. The primary endpoint examines the responder rate and mean change in Tinnitus Handicap Inventory (THI) after ~12 weeks of treatment in eligible patients with moderate or worse tinnitus. A responder represents a THI improvement of greater than seven points (i.e., minimal clinically important difference, MCID).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here we show that, out of 212 patients with available data, there was a high responder rate of 91.5% (95% CI: 86.9%, 94.5%) with a mean improvement of 27.8\u2009\u00b1\u20091.3 (SEM) points, and no device-related serious adverse events. Furthermore, a THI MCID of seven points represents a consistent criterion for clinical benefit based on evidence from clinical practice settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings show that the Lenire device can be used to safely and effectively reduce tinnitus in a real-world clinical setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-025-00837-3","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:02:48Z","timestamp":1745816568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for tinnitus treatment in a clinical setting"],"prefix":"10.1038","volume":"5","author":[{"given":"Emily E.","family":"McMahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5653-9679","authenticated-orcid":false,"given":"Hubert H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"837_CR1","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(13)60142-7","volume":"382","author":"D Baguley","year":"2013","unstructured":"Baguley, D., McFerran, D. & Hall, D. Tinnitus. Lancet 382, 1600\u20131607 (2013).","journal-title":"Lancet"},{"key":"837_CR2","doi-asserted-by":"crossref","unstructured":"Biswas, R. & Hall, D. A. Prevalence, incidence, and risk factors for tinnitus. In The Behavioral Neuroscience of Tinnitus (ed. Searchfield, G.D. & Zhang, J.) 3\u201328 (Springer, 2020).","DOI":"10.1007\/7854_2020_154"},{"key":"837_CR3","first-page":"100250","volume":"12","author":"R Biswas","year":"2022","unstructured":"Biswas, R. et al. Tinnitus prevalence in Europe: a multi-country cross-sectional population study. Lancet Reg. Health\u2013Eur. 12, 100250 (2022).","journal-title":"Lancet Reg. Health\u2013Eur."},{"key":"837_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0030-6665(02)00160-3","volume":"36","author":"AJ Heller","year":"2003","unstructured":"Heller, A. J. Classification and epidemiology of tinnitus. Otolaryngol. Clin. N. Am. 36, 239\u2013248 (2003).","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"837_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.heares.2016.05.009","volume":"337","author":"A McCormack","year":"2016","unstructured":"McCormack, A., Edmondson-Jones, M., Somerset, S. & Hall, D. A systematic review of the reporting of tinnitus prevalence and severity. Hear. Res. 337, 70\u201379 (2016).","journal-title":"Hear. Res."},{"key":"837_CR6","doi-asserted-by":"crossref","unstructured":"M\u00f8ller, A. R., Langguth, B., DeRidder, D. & Kleinjung, T. Textbook of Tinnitus (Springer Science & Business Media, 2010).","DOI":"10.1007\/978-1-60761-145-5"},{"key":"837_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00106-019-0633-7","volume":"67","author":"R Cima","year":"2019","unstructured":"Cima, R. et al. A multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment. HNO 67, 10\u201342 (2019).","journal-title":"HNO"},{"key":"837_CR8","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.3390\/jcm12093087","volume":"12","author":"B Langguth","year":"2023","unstructured":"Langguth, B., Kleinjung, T., Schlee, W., Vanneste, S. & De Ridder, D. Tinnitus guidelines and their evidence base. J. Clin. Med. 12, 3087 (2023).","journal-title":"J. Clin. Med."},{"key":"837_CR9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0194599814533287","volume":"151","author":"DE Tunkel","year":"2014","unstructured":"Tunkel, D. E. et al. Clinical practice guideline: tinnitus. Otolaryngol.\u2013Head Neck Surg. 151, S1\u2013S40 (2014).","journal-title":"Otolaryngol.\u2013Head Neck Surg."},{"key":"837_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3766\/jaaa.19022","volume":"31","author":"R Tyler","year":"2020","unstructured":"Tyler, R., Perreauf, A., Mohr, A.-M., Ji, H. & Mancini, P. C. An exploratory step toward measuring the \u201cmeaning of life\u201d in patients with tinnitus and in cochlear implant users. J. Am. Acad. Audiol. 31, 277\u2013285 (2020).","journal-title":"J. Am. Acad. Audiol."},{"key":"837_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep09462","volume":"5","author":"CD Markovitz","year":"2015","unstructured":"Markovitz, C. D., Smith, B. T., Gloeckner, C. D. & Lim, H. H. Investigating a new neuromodulation treatment for brain disorders using synchronized activation of multimodal pathways. Sci. Rep. 5, 1\u201312 (2015).","journal-title":"Sci. Rep."},{"key":"837_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50473-z","volume":"15","author":"M Boedts","year":"2024","unstructured":"Boedts, M. et al. Combining sound with tongue stimulation clinically improves tinnitus symptoms in a controlled pivotal trial. Nat. Commun. 15, 6806 (2024).","journal-title":"Nat. Commun."},{"key":"837_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13875-x","volume":"12","author":"B Conlon","year":"2022","unstructured":"Conlon, B. et al. Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial. Sci. Rep. 12, 10845 (2022).","journal-title":"Sci. Rep."},{"key":"837_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb2830","volume":"12","author":"B Conlon","year":"2020","unstructured":"Conlon, B. et al. Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study. Sci. Transl. Med. 12, eabb2830 (2020).","journal-title":"Sci. Transl. Med."},{"key":"837_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/0194599811403882","volume":"145","author":"F Zeman","year":"2011","unstructured":"Zeman, F. et al. Tinnitus handicap inventory for evaluating treatment effects: which changes are clinically relevant? Otolaryngol.-Head. Neck Surg. 145, 282\u2013287 (2011).","journal-title":"Otolaryngol.-Head. Neck Surg."},{"key":"837_CR16","volume":"4","author":"US Department of Health and Human Services. FDA Center for Drug Evaluation and Research. Guidelines for Industry","year":"2006","unstructured":"US Department of Health and Human Services. FDA Center for Drug Evaluation and Research. Guidelines for Industry Patient-reported outcome measures: use in medical product development to support labeling claims. Health Qual. Life Outcomes 4, 1 (2006).","journal-title":"Health Qual. Life Outcomes"},{"key":"837_CR17","doi-asserted-by":"publisher","first-page":"e39076","DOI":"10.2196\/39076","volume":"25","author":"S Demoen","year":"2023","unstructured":"Demoen, S. et al. Effectiveness of telerehabilitation interventions for self-management of tinnitus: systematic review. J. Med. Internet Res. 25, e39076 (2023).","journal-title":"J. Med. Internet Res."},{"key":"837_CR18","doi-asserted-by":"publisher","first-page":"e13176","DOI":"10.2196\/13176","volume":"8","author":"B Conlon","year":"2019","unstructured":"Conlon, B. et al. Noninvasive bimodal neuromodulation for the treatment of tinnitus: protocol for a second large-scale double-blind randomized clinical trial to optimize stimulation parameters. JMIR Res. Protoc. 8, e13176 (2019).","journal-title":"JMIR Res. Protoc."},{"key":"837_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/archotol.1996.01890140029007","volume":"122","author":"CW Newman","year":"1996","unstructured":"Newman, C. W., Jacobson, G. P. & Spitzer, J. B. Development of the tinnitus handicap inventory. Arch. Otolaryngol.\u2013Head. Neck Surg. 122, 143\u2013148 (1996).","journal-title":"Arch. Otolaryngol.\u2013Head. Neck Surg."},{"key":"837_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/03655230600895424","volume":"126","author":"RS Tyler","year":"2006","unstructured":"Tyler, R. S., Noble, W. & Coelho, C. Considerations for the design of clinical trials for tinnitus. Acta Otolaryngol. 126, 44\u201349 (2006).","journal-title":"Acta Otolaryngol."},{"key":"837_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0079-6123(07)66048-8","volume":"166","author":"RS Tyler","year":"2007","unstructured":"Tyler, R. S., Oleson, J., Noble, W., Coelho, C. & Ji, H. Clinical trials for tinnitus: study populations, designs, measurement variables, and data analysis. Prog. Brain Res. 166, 499\u2013509 (2007).","journal-title":"Prog. Brain Res."},{"key":"837_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1044\/1092-4388(2005\/084)","volume":"48","author":"JA Henry","year":"2005","unstructured":"Henry, J. A., Dennis, K. C. & Schechter, M. A. General review of tinnitus. J. Speech Lang. Hear. Res. 48, 5 (2005).","journal-title":"J. Speech Lang. Hear. Res."},{"key":"837_CR23","first-page":"959","volume":"142","author":"JM Bhatt","year":"2016","unstructured":"Bhatt, J. M., Lin, H. W. & Bhattacharyya, N. Prevalence, severity, exposures, and treatment patterns of tinnitus in the United States. Otolaryngol. Head Neck Surg. 142, 959\u2013965 (2016).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"837_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fnins.2020.00487","volume":"14","author":"U Niemann","year":"2020","unstructured":"Niemann, U., Boecking, B., Brueggemann, P., Mazurek, B. & Spiliopoulou, M. Gender-specific differences in patients with chronic tinnitus\u2014baseline characteristics and treatment effects. Front. Neurosci. 14, 487 (2020).","journal-title":"Front. Neurosci."},{"key":"837_CR25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1046\/j.1365-2273.2001.00490.x","volume":"26","author":"A McCombe","year":"2001","unstructured":"McCombe, A. et al. Guidelines for the grading of tinnitus severity: the results of a working group commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons, 1999. Clin. Otolaryngol. Allied Sci. 26, 388\u2013393 (2001).","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"837_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12178-w","volume":"7","author":"R Tyler","year":"2017","unstructured":"Tyler, R. et al. Vagus nerve stimulation paired with tones for the treatment of tinnitus: a prospective randomized double-blind controlled pilot study in humans. Sci. Rep. 7, 1\u201311 (2017).","journal-title":"Sci. Rep."},{"key":"837_CR27","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.3390\/jcm12227117","volume":"12","author":"B Langguth","year":"2023","unstructured":"Langguth, B. & De Ridder, D. Minimal clinically important difference of tinnitus outcome measurement instruments\u2014a scoping review. J. Clin. Med. 12, 7117 (2023).","journal-title":"J. Clin. Med."},{"key":"837_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.brs.2022.01.022","volume":"15","author":"A Buechner","year":"2022","unstructured":"Buechner, A., Lesinski-Schiedat, A., Becker, P. & Lenarz, T. Real-world clinical experience with bimodal neuromodulation for the treatment of tinnitus\u2014a case series. Brain Stimul.: Basic Transl. Clin. Res. Neuromodul. 15, 383\u2013384 (2022).","journal-title":"Brain Stimul.: Basic Transl. Clin. Res. Neuromodul."},{"key":"837_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/1357633X211022907","volume":"29","author":"CL Snoswell","year":"2023","unstructured":"Snoswell, C. L. et al. The clinical effectiveness of telehealth: a systematic review of meta-analyses from 2010 to 2019. J. Telemed. Telecare 29, 669\u2013684 (2023).","journal-title":"J. Telemed. Telecare"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00837-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00837-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00837-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:02:53Z","timestamp":1745816573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00837-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00837-3","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: E.E.M. is a commercial provider of the Lenire treatment for patients with tinnitus and H.H.L. is a consultant with financial interests for Neuromod Devices.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}